JD

Jen DeFerrari

Executive Director, Finance at Celldex Therapeutics

Jen DeFerrari has extensive work experience in finance and accounting. Jen started their career at PricewaterhouseCoopers as a Senior Associate from September 2008 to October 2011. Jen then joined Nuance Communications, where they held various roles including Senior Accountant in M&A from October 2012 to June 2014, Senior Accountant in Technical Revenue Accounting from June 2014 to October 2015, and finally as Technical Revenue Accounting Manager from October 2015 to June 2018.

In 2018, Jen joined Celldex Therapeutics as the Director of Financial Reporting, Planning and Analysis. Jen held this role until January 2021 when they were promoted to Senior Director of Finance. Jen currently works in this position, contributing their expertise to the company.

Jen DeFerrari obtained a Bachelor of Science degree in Business Administration from Boston University, where they studied from 2004 to 2008. Following their undergraduate education, they attained the Certified Public Accountant certification from the American Institute of Certified Public Accountants (AICPA) in January 2010.

Links

Previous companies

PwC logo

Timeline

  • Executive Director, Finance

    January 1, 2024 - present

  • Senior Director, Finance

    January, 2021

  • Director of Financial Reporting, Planning and Analysis

    July, 2018

View in org chart